Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3820704, 8 pages
http://dx.doi.org/10.1155/2016/3820704
Research Article

Analgesic and Antipyretic Activities of Methanol Extract and Its Fraction from the Root of Schoenoplectus grossus

1Faculty of Pharmacy, Little Buddha College of Health Science, Purbanchal University, Kathmandu 44600, Nepal
2Department of Clinical Pharmacy & Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh

Received 1 October 2015; Revised 4 January 2016; Accepted 12 January 2016

Academic Editor: Olumayokun A. Olajide

Copyright © 2016 Nirmal Kumar Subedi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Castellsague, N. Riera-Guardia, B. Calingaert et al., “Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS Project),” Drug Safety, vol. 35, no. 12, pp. 1127–1146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Ofman, C. H. MacLean, W. L. Straus et al., “A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs,” The Journal of Rheumatology, vol. 29, no. 4, pp. 804–812, 2002. View at Google Scholar · View at Scopus
  3. J. Hippisley Cox and C. Coupland, “Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis,” British Medical Journal, vol. 330, no. 7504, article 1366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Jüni, L. Nartey, S. Reichenbach, R. Sterchi, P. A. Dieppe, and P. M. Egger, “Risk of cardiovascular events and rofecoxib: cumulative meta-analysis,” The Lancet, vol. 364, no. 9450, pp. 2021–2029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Mamdani, D. N. Juurlink, D. S. Lee et al., “Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study,” The Lancet, vol. 363, no. 9423, pp. 1751–1756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lenzer, “FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke,” British Medical Journal, vol. 330, no. 7489, p. 440, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Benyamin, A. M. Trescot, S. Datta et al., “Opioid complications and side effects,” Pain Physician, vol. 11, no. 2, pp. S105–S120, 2008. View at Google Scholar · View at Scopus
  8. C. J. Phillips, “Economic burden of chronic pain,” Expert Review of Pharmacoeconomics & Outcomes Research, vol. 6, no. 5, pp. 591–601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Hewitt, R. J. Hargreaves, S. P. Curtis, and D. Michelson, “Challenges in analgesic drug development,” Clinical Pharmacology & Therapeutics, vol. 86, no. 4, pp. 447–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. Robinon and X. Zhang, The World Medicine Situation (Traditional Medicines: Global Situation, Issues and Challenges). Geneva, World Health Organization, Geneva, Switzerland, 2011.
  11. A. Ghani, Medicinal Plants of Bangladesh, The Asiatic Society of Bangladesh, Ramna, Bangladesh, 2nd edition, 2003.
  12. A. H. Beckett and J. B. Stenlake, Chromatography: Practical Pharmaceutical Chemistry, The Athlone Press, London, UK, 3rd edition, 1986.
  13. G. E. Trease and W. Evans, A Text Book of Pharmacognosy, Cambridge University Press, London, UK, 13th edition, 1989.
  14. R. Koster, M. Anderson, and E. J. De Beer, “Acetic acid-induced analgesic screening,” Federation Proceedings, vol. 18, pp. 412–417, 1959. View at Google Scholar
  15. F. E. D'amour and D. L. Smith, “A method for determining loss of pain sensation,” Journal of Pharmacology and Experimental Therapeutics, vol. 72, no. 1, pp. 74–79, 1941. View at Google Scholar
  16. J. Tomazetti, D. S. Ávila, A. P. Ferreira et al., “Baker yeast-induced fever in young rats: characterization and validation of an animal model for antipyretics screening,” Journal of Neuroscience Methods, vol. 147, no. 1, pp. 29–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Turner, Screening Methods in Pharmacology, Academic Press, New York, NY, USA, 1965.
  18. G. A. Bentley, S. H. Newton, and J. Starr, “Studies on the antinociceptive action of α-agonist drugs and their interactions with opioid mechanisms,” British Journal of Pharmacology, vol. 79, no. 1, pp. 125–134, 1983. View at Publisher · View at Google Scholar · View at Scopus
  19. H. O. Collier, L. C. Dinneen, C. A. Johnson, and C. Schneider, “The abdominal constriction response and its suppression by analgesic drugs in the mouse,” British Journal of Pharmacology and Chemotherapy, vol. 32, no. 2, pp. 295–310, 1968. View at Google Scholar · View at Scopus
  20. G. F. Pavao-de-Souza, A. C. Zarpelon, G. C. Tedeschi et al., “Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI3K and microglia in mice,” Pharmacology Biochemistry and Behavior, vol. 101, no. 3, pp. 320–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Deraedt, S. Jouquey, F. Delevallée, and M. Flahaut, “Release of prostaglandins E and F in an algogenic reaction and its inhibition,” European Journal of Pharmacology, vol. 61, no. 1, pp. 17–24, 1980. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Berkenkopf and B. M. Weichman, “Production of prostacyclin in mice following intraperitoneal injection of acetic acid, phenylbenzoquinone and zymosan: its role in the writhing response,” Prostaglandins, vol. 36, no. 5, pp. 693–709, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. J. D. Levine, W. Lau, G. Kwiat, and E. J. Goetzl, “Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes,” Science, vol. 225, no. 4663, pp. 743–745, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Ribeiro, M. L. Vale, S. M. Thomazzi et al., “Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice,” European Journal of Pharmacology, vol. 387, no. 1, pp. 111–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Amico-Roxas, A. Caruso, S. Trombadore, R. Scifo, and U. Scapagnini, “Gangliosides antinociceptive effects in rodents,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 272, no. 1, pp. 103–117, 1984. View at Google Scholar · View at Scopus
  26. P. Davies, P. J. Bailey, M. M. Goldenberg, and A. W. Ford-Hutchinson, “The role of arachidonic acid oxygenation products in pain and inflammation,” Annual Review of Immunology, vol. 2, no. 1, pp. 335–357, 1984. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Vogel, Drug Discovery and Evaluation: Pharmacological Assays, Springer, Berlin, Germany, 2007.
  28. A. Tjølsen and K. Hole, “Tail-Flick test,” in Encyclopedia of Pain, G. Gebhart and R. Schmidt, Eds., pp. 3832–3837, Springer, Berlin, Germany, 2013. View at Google Scholar
  29. C. R. Chapman, K. L. Casey, R. Dubner, K. M. Foley, R. H. Gracely, and A. E. Reading, “Pain measurement: an overview,” Pain, vol. 22, no. 1, pp. 1–31, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Gårdmark, A. U. Höglund, and M. Hammarlund-Udenaes, “Aspects on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception,” Pharmacology and Toxicology, vol. 83, no. 6, pp. 252–258, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Fan, N. A. Ali, and D. F. Basri, “Evaluation of analgesic activity of the methanol extract from the galls of Quercus infectoria (Olivier) in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 976764, 6 pages, 2014. View at Publisher · View at Google Scholar
  32. E. A. Asongalem, H. S. Foyet, S. Ekobo, T. Dimo, and P. Kamtchouing, “Antiinflammatory, lack of central analgesia and antipyretic properties of Acanthus montanus (Ness) T. Anderson,” Journal of Ethnopharmacology, vol. 95, no. 1, pp. 63–68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. J. S. M. Pasin, A. P. O. Ferreira, A. L. L. Saraiva et al., “Diacerein decreases TNF-α and IL-1β levels in peritoneal fluid and prevents Baker's yeast-induced fever in young rats,” Inflammation Research, vol. 59, no. 3, pp. 189–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. N. Luheshi, “Cytokines and fever: mechanisms and sites of action,” Annals of the New York Academy of Sciences, vol. 856, pp. 83–89, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. C. B. Saper and C. D. Breder, “The neurologic basis of fever,” The New England Journal of Medicine, vol. 330, no. 26, pp. 1880–1886, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. W. L. Veale, K. E. Cooper, and Q. J. Pittman, “Role of prostaglandins in fever and temperature regulation,” in The Prostaglandins, P. Ramwell, Ed., pp. 145–167, Springer, New York, NY, USA, 1977. View at Google Scholar
  37. D. M. Aronoff and E. G. Neilson, “Antipyretics: mechanisms of action and clinical use in fever suppression,” The American Journal of Medicine, vol. 111, no. 4, pp. 304–315, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Afsar, M. R. Khan, S. Razak, S. Ullah, and B. Mirza, “Antipyretic, anti-inflammatory and analgesic activity of Acacia hydaspica R. Parker and its phytochemical analysis,” BMC Complementary and Alternative Medicine, vol. 15, article 136, 2015. View at Publisher · View at Google Scholar
  39. A. Rauf, G. Uddin, B. S. Siddiqui, N. Muhammad, and H. Khan, “Antipyretic and antinociceptive activity of Diospyros lotus L. in animals,” Asian Pacific Journal of Tropical Biomedicine, vol. 4, supplement 1, pp. S382–S386, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Kumar, K. Agarwal, A. K. Maurya et al., “Pharmacological and phytochemical evaluation of Ocimum sanctum root extracts for its antiinflammatory, analgesic and antipyretic activities,” Pharmacognosy Magazine, vol. 11, no. 42, supplement 1, pp. S217–S224, 2015. View at Publisher · View at Google Scholar
  41. G. S. B. Viana, M. A. M. Bandeira, L. C. Moura, M. V. P. Souza-Filho, F. J. A. Matos, and R. A. Ribeiro, “Analgesic and antiinflammatory effects of the tannin fraction from Myracrodruon urundeuva Fr. All,” Phytotherapy Research, vol. 11, no. 2, pp. 118–122, 1997. View at Google Scholar · View at Scopus
  42. Y. Goda, F. Kiuchi, M. Shibuya, and U. Sankawa, “Inhibitors of prostaglandin biosynthesis from Dalbergia odorifera,” Chemical and Pharmaceutical Bulletin, vol. 40, no. 9, pp. 2452–2457, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Dames, V. Bourdon, G. Remacle-Uolon, and J. Lecomte, “Pro-inflammatory flavonoids which are inhibitors of prostaglandin biosynthesis,” Prostaglandins, Leukotrienes and Medicine, vol. 19, no. 1, pp. 11–24, 1985. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Robak and R. J. Gryglewski, “Bioactivity of flavonoids,” Polish Journal of Pharmacology, vol. 48, no. 6, pp. 555–564, 1996. View at Google Scholar · View at Scopus
  45. M. Tordera, M. L. Ferrandiz, and M. J. Alcaraz, “Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils,” Zeitschrift für Naturforschung C—Journal of Biosciences, vol. 49, no. 3-4, pp. 235–240, 1994. View at Google Scholar · View at Scopus